International
‘Partial’ Lockdowns Expand In Europe, New COVID-19 Cases Climb In China, Hong Kong: Live Updates
‘Partial’ Lockdowns Expand In Europe, New COVID-19 Cases Climb In China, Hong Kong: Live Updates

Summary:
- US strikes $2.1 billion deal with GSK, Sanofi
- UK extends 'partial' lockdown to 4 million people
- Cases climb in China, HK
- HK cancels September vote
- Australia's Victoria state sees second-highest daily tally
- Argentina sees record daily jump
* * *
US markets are buzzed off last night's quartet of big-tech earnings reports that absolutely demolished Wall Street projections (is that really such a surprise?), but signs that the virus is reemerging in Europe and Asia have continued to hector investors, politicians, business-owners and taxpayers alike.
Last night, we reported that UK PM Boris Johnson had ordered a large swath of northern England to return to 'partial' lockdown status.
These new 'partial' lockdown rules affect 4 million people across the region. If the UK seems a little trigger happy, it's not without reason: Catalonia is seeing a serious resurgence of COVID-19, prompting local officials to issue new lockdown orders, while several European states issue travel restrictions or advisories targeting Spain, which has prompted the country to grouse about the damage to its tourism industry.
Bloomberg reported Friday that NYC is doomed for a resurgence of the virus in the fall, even as its infection rates continue to fall.
Why is Bloomberg so worried? Well, Melbourne, which has seen infections continue to climb despite strict lockdown measures and other social distancing procedures, is at the epicenter of a resurgence in Australia, which reported
The city has been a success story in combating Covid-19 since March and April, when the pandemic swept through its boroughs killing thousands of people. Yet the strategies that helped suppress the first surge -- dropping the infection rate to just 1% statewide -- will be tested as cooler weather pushes people together indoors.
[...]
Melbourne, Australia, with 5 million people, offers a case in point. With the Fahrenheit dropping into the 50s, Melbourne has seen an upswing in cases, a foreboding indicator of how tough it may be for cities like New York to control infections as the mercury drops. With fall and winter approaching, it’s “inevitable” Covid-19 cases will tick up, said Ashish Jha, director of Harvard University’s Global Health Institute.
“I am worried about complacency,” Jha said in an interview. “New York went through such a difficult few months, and I am worried that people are tired. A lot of people are looking at New York over the next six months and saying: ‘Could we possibly see a spike?'"
Australia’s second-most populous state reported 627 new cases in the past 24 hours, a day after suffering a record 723 new cases. There were also 8 more deaths. The situation in Victoria has prompted experts to start to question the benefits of mass lockdowns, as such restrictive measures have had little impact on Melbourne's outbreak.
Hong Kong - which cancelled fall elections - and mainland China are also seeing cases rise: The mainland reported 123 local coronavirus infections for July 30, including 112 in Xinjiang and 11 in Liaoning, according to China's NHC. 4 cases were also imported. Friday's total number reported was higher than the 105 new cases reported in the mainland on Thursday.
Finally, Argentina posted a record 6,377 new cases, bringing the country’s total to 185,373. It also reported 130 new deaths, taking the death toll to 3,441.
Across the US, the number of new cases have started to plateau as new cases and the positivity rate across the Sun Belt have both declined (the number of tests carried out across the hardest hit states has also started to decline)...
...while daily deaths continue to creep higher.
COVID-19's global rebound shows us just how difficult it can be to stop such an infectious virus without sufficient levels of immunity within the population. Former FDA Director Scott Gottlieb once warned that the outbreak should be finished by January no matter what - either it will have run its course, or a vaccine will be made widely available.
Governments around the world have scrambled to strike deals with the companies leading the race for a vaccine, including Moderna, Pfizer, Astrazeneca, GSK and Sanofi, etc. Highly publicized deals have mostly focused on the most advanced vaccine trials: Which is why, after inking a record $2 billion deal with Pfizer, the US government on Friday reportedly signed a similar deal with Sanofi and GSK, mirroring a deal between the UK and the UK-based drug makers announced earlier this week.
The money comes via "Operation Warp Speed", the Trump Administration program to simply throw money at vaccine candidates. the US will pay $2.1 billion to secure 100 million doses while supporting manufacturing and the expensive clinical trials. Here's more on that from BBG:
The Trump administration will provide as much as $2.1 billion to Covid-19 vaccine partners Sanofi and GlaxoSmithKline Plc, the biggest U.S. investment yet in fast-tracking shots and snapping up supplies.
Part of Operation Warp Speed, the funding will support clinical trials and manufacturing while allowing the U.S. to secure 100 million doses of the shot, if it’s successful, the companies said Friday. The country has an option to receive an additional 500 million doses longer term.
Glaxo shares traded 0.6% higher in London, with Sanofi up 1.3% in Paris.
The deal follows billions of dollars of U.S. commitments to other experimental vaccines - all still needing to show their effectiveness in testing - and may stoke concerns that other countries will be left behind. Vaccines are seen as the key to leading the world out of the pandemic that has killed about 675,000 people in a matter of months.
Like with the Pfizer deal, the US has an option to receive an additional 500 million doses longer term if the vaccine works out.
International
Stock Market Today: Stocks turn lower as Treasury yield rise mutes earnings gains
A mixed set of big tech earnings, alongside modestly higher Treasury yields, has stocks moving lower into the start of the Wednesday session.

- Action Alerts PLUS offers expert portfolio guidance to help you make informed investing decisions. Sign up now.
International
People in Europe ate seaweed for thousands of years before it largely disappeared from their diets – we wonder why?
The decline of seaweed as part of the staple diet in Europe remains a mystery.

How are we sure people ate seaweed?
We identified several types of molecules in the dental calculus that collectively are characteristic of seaweed. We refer to these as “biomarkers”. They include a set of chemical compounds called alkylpyrroles. When we detect these compounds together in calculus, we can be fairly sure where they came from. The same goes for other compounds characteristic of seaweed and freshwater plants. To have become embedded in dental calculus, the seaweed and freshwater plants had to have been in the mouth and most probably chewed. Biomarkers do not survive in all our samples, but where they do, they’re found consistently across many individuals we analysed from different places. This suggests seaweed was probably a routine part of the diet.Perceptions of seaweed
Today, seaweed is often seen as the scourge of beaches. It accumulates at the high-water mark where it can create a slippery and sometimes smelly barrier to the sea. But it is a wondrous world of its own. There are over 10,000 species of seaweed worldwide living in the intertidal zone (where the ocean meets the land between high and low tides) and the subtidal zone (a region below the intertidal zone that is continuously covered by water). Around 145 of these species are eaten today and in parts of Asia it is commonplace. Seaweed is edible, nutritious, sometimes medicinal, abundant and local. Although overconsumption can cause iodine toxicity, there are no poisonous intertidal species in Europe. It is also available all year round, which would have been particularly useful in the past, when food supplies were less reliable.Reconstructing ancient diets
Reconstructing ancient diets is challenging and is generally more difficult as you go back in time. This helps explain why we’ve only just realised how much seaweed was being eaten by ancient Europeans. In archaeology, evidence for ancient diets often comes from physical remains: animal bones, fish bones and the hard parts of shellfish. Evidence for plants as part of the diet before farming, however, is rare. Techniques to study molecules from archaeological remains have been around for some time. A key method is known as carbon/nitrogen (C and N) stable isotope analysis. This is widely used to reconstruct ancient human and animal diets based on the relative proportions of these elements in bone collagen. But the presence of plants has been difficult to identify, due to their low nitrogen content. Their presence is masked by an overwhelming signal for animals and fish.Hiding in plain sight
The evidence for seaweed had been present all along, but unrecognised. Our discovery provides a perfect example of how perceptions of what we regard as food influence interpretations of ancient practices. Seaweed was detected in chunks that had been chewed (and presumably spat out) at the 12,000-year-old site of Monte Verde, Chile. But when it is found at archaeological sites, it is more commonly interpreted as having been used for things other than food, such as fuel and food wrappings. In European archaeology, there is a longstanding perception that Mesolithic hunter-gatherers ate lots of seafood, but that when people started farming, they focused on food sourced from land, such as their livestock. Our findings hammer another nail into the coffin of this theory. Today, only a few traditional recipes remain, such as laverbread made from the seaweed species Porphyra umbilicalis in Wales. It’s still not clear why seaweed declined as a staple source of food in Europe after the Middle Ages.What are the implications?
Our unexpected discovery changes the way we understand past people. It also alters our perceptions of how they understood the landscape and how they exploited local resources. It suggests, not for the first time, that we vastly underestimate ancient people. They had a knowledge, particularly about the natural world, that is difficult for us to imagine today. The finding also reminds us that archaeological remains are minute windows into the past, reinforcing the care required when developing theories based on limited evidence. The consumption of plants, upon which our world depends, has been habitually left out of dietary theories from our pre-agrarian past. Rigid theories have sometimes forgotten that humans were behind these archaeological cultures – and that they were probably similar to us in their curiosity and needs. Today seaweed sits, largely unused as food, on our doorstep. Making the edible species a bigger component of our diets could even contribute to making our food supplies more sustainable.
The authors do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.
european europeInternational
EUR/AUD bearish breakdown supported by additional China fiscal stimulus and AU inflation
Weak PMI readings from the Eurozone, an increase in China’s budget deficit ratio, and renewed inflationary pressures in Australia may trigger a persistent…

- Weak PMI readings from the Eurozone, an increase in China’s budget deficit ratio, and renewed inflationary pressures in Australia may trigger a persistent bearish sentiment loop in EUR/AUD.
- Watch the key short-term resistance at 1.6700 for EUR/AUD.
- A break below 1.6250 key medium-term support on the EUR/AUD may trigger a multi-week bearish impulsive down move.
The Euro (EUR) tumbled overnight throughout the US session as it erased its prior gains against the US dollar recorded on Monday, 23 October; the EUR/USD shed -104 pips from yesterday’s intraday high of 1.0695 to close the US session at 1.0591, its weakest performance in the past seven sessions.
Yesterday’s resurgence of the USD dollar strength has been attributed to a robust set of October flash manufacturing and services PMI data from the US in contrast with weak readings seen in the UK and Eurozone that represented stagflation risks.
Interestingly, the Aussie dollar (AUD) has outperformed the US dollar where the AUD/USD managed to squeeze out a minor daily gain of 21 pips by the close of yesterday’s US session. The resilient movement of the AUD/USD has been impacted by positive news flow out from China, Australia’s key trading partner.
China’s national legislature has just approved a budgetary plan to raise the fiscal deficit ratio for 2023 to around 3.8% of its GDP which was above the initial 3% set in March and set to issue additional sovereign debt worth 1 trillion yuan in Q4. This latest round of additional fiscal stimulus suggests that China’s top policymakers are expanding their initial targeted measures to address the ongoing severe liquidity crunch in the domestic property market as well as to reverse the persistent weak sentiment inherent in the stock market.
In addition, the latest set of Australia’s inflation data surpassed expectations has also reinforced another layer of positive feedback loop in the Aussie dollar which in turn may put Australia’s central bank, RBA on a “hawkish guard” against cutting its policy cash rate too soon.
The less lagging monthly CPI Indicator has risen to an annualized rate of 5.6% in September, above consensus estimates of 5.4%, and surpassed August’s reading of 5.2% which has translated into a second consecutive month of uptick in inflationary growth.
In the lens of technical analysis, a potential bearish configuration setup has emerged in the EUR/AUD cross pair from a short to medium-term perspective.
Major uptrend phase of EUR/AUD is weakening
Fig 1: EUR/AUD medium-term trend as of 25 Oct 2023 (Source: TradingView, click to enlarge chart)
Even though the price actions of the EUR/AUD have been oscillating within a major ascending channel since its 25 August 2023 low of 1.4285 and traded above the key 200-day moving average so far, the momentum of this up movement is showing signs of bullish exhaustion.
Yesterday (24 October) price action ended with a daily bearish reversal “Marubozu” candlestick coupled with the daily RSI momentum indicator that retreated right at a significant parallel resistance in place since March 2023 at the 65 level which suggests a revival of medium-term bearish momentum.
EUR/AUD bears are now attacking the minor ascending support
Fig 2: EUR/AUD minor short-term trend as of 25 Oct 2023 (Source: TradingView, click to enlarge chart)
The EUR/AUD has now staged a bearish price action follow-through via the breakdown of its minor ascending support from its 29 September 2023 low after a momentum bearish breakdown that was flashed earlier yesterday (24 October) during the European session as seen from the 4-hour RSI momentum indicator.
Watch the 1.6700 key short-term pivotal resistance (also the 50-day moving average) for a further potential slide toward the intermediate supports of 1.6460 and 1.6320 in the first step.
On the other hand, a clearance above 1.6700 invalidates the bearish tone to see the next intermediate resistance coming in at 1.6890.
stimulus budget deficit us dollar euro yuan gdp stimulus european uk china-
Uncategorized22 hours ago
New Home Sales increase to 759,000 Annual Rate in September
-
International22 hours ago
People in Europe ate seaweed for thousands of years before it largely disappeared from their diets – we wonder why?
-
Uncategorized22 hours ago
Bitcoin = Anti-Totalitarianism
-
International22 hours ago
Stock Market Today: Stocks turn lower as Treasury yield rise mutes earnings gains
-
Uncategorized22 hours ago
5,050 Bitcoin for $5 in 2009: Helsinki’s claim to crypto fame